CLOs on the Move

Alaska Glass and Door

www.alaskaglassanddoor.com

 
Alaska Glass & Door Llc is a Wasilla, AK-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Niagara Ceramics Corporation

Niagara Ceramics Corporation is a Buffalo, NY-based company in the Business Services sector.

legiornatedellaluce

#Festival a #Spilimbergo #legiornatedellaluce 9-17 giugno 2018. Premio al miglior autore della #fotografia del #cinema #italiano. #cultura #arte #fvg

Mancon

MANCON will not provide all supplies. Districts will still continue to purchase and inventory grass seed, stone, traffic paint, lumber and other road stock items resulting in the continued use of Capital Asset and Inventory Control Division's Inventory

Captive Media Inc

Captive Media Inc is a Encino, CA-based company in the Business Services sector.

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.